Citigroup Reiterates “Buy” Rating for Stryker (NYSE:SYK)
Stryker (NYSE:SYK – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at Citigroup in a research report issued on Wednesday, Marketbeat reports. They currently have a $450.00 price objective on the medical technology company’s stock. Citigroup’s price target points to a potential upside of 15.65% from the stock’s current price. A […]
Stryker (NYSE:SYK – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at Citigroup in a research report issued on Wednesday, Marketbeat reports. They currently have a $450.00 price objective on the medical technology company’s stock. Citigroup’s price target points to a potential upside of 15.65% from the stock’s current price. A […]
